Menu Search
Equities

Lumos Diagnostics Holdings Ltd

LDX:ASX

Lumos Diagnostics Holdings Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.032
  • Today's Change0.002 / 6.67%
  • Shares traded2.04m
  • 1 Year change-52.63%
  • Beta1.4514
Data delayed at least 20 minutes, as of Nov 15 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Lumos Diagnostics Holdings Ltd grew revenues 5.66% from 10.54m to 11.13m while net income improved from a loss of 8.97m to a smaller loss of 8.59m.
Gross margin63.77%
Net profit margin-77.19%
Operating margin-67.55%
Return on assets-32.88%
Return on equity-103.47%
Return on investment-54.62%
More ▼

Cash flow in USDView more

In 2024, Lumos Diagnostics Holdings Ltd increased its cash reserves by 114.89%, or 3.46m. Cash Flow from Financing totalled 2.63m or 23.63% of revenues. In addition the company generated 946.00k in cash from operations while cash used for investing totalled 98.00k.
Cash flow per share-0.0187
Price/Cash flow per share--
Book value per share0.0215
Tangible book value per share-0.0078
More ▼

Balance sheet in USDView more

Lumos Diagnostics Holdings Ltd has a Debt to Total Capital ratio of 53.14%, a lower figure than the previous year's 81.57%.
Current ratio0.757
Quick ratio0.6949
Total debt/total equity1.13
Total debt/total capital0.5314
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.